Clinical Trial Update: "The Once A Day Protease Inhibitor Regimens" [Phase 4]

View source ↗

Summary

Phase IV clinical trial update on once-daily protease inhibitor regimens for HIV infection; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2013-10-17